Statistical Considerations for Testing Multiple Endpoints in Group Sequential or Adaptive Clinical Trials

ISSN： 1054-3406

Source： Journal of Biopharmaceutical Statistics, Vol.17, Iss.6, 2007-11, pp. : 1201-1210

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adaptive Group Sequential Test for Clinical Trials with Changing Patient Population

By Feng Huaibao

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 6, 2007-11 ,pp. : 1227-1238

Taylor & Francis Ltd

Access to resources Recommend Favorite

Group-Sequential Methods for Adaptive Seamless Phase II/III Clinical Trials

By Stallard Nigel

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 4, 2011-07 ,pp. : 787-801

Taylor & Francis Ltd

Access to resources Recommend Favorite

Adaptive Sequential Testing for Multiple Comparisons

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 5, 2014-09 ,pp. : 1035-1058

Taylor & Francis Ltd

Access to resources Recommend Favorite

Sample Size Re-Estimation for Adaptive Sequential Design in Clinical Trials

By Gao Ping

Journal of Biopharmaceutical Statistics, Vol. 18, Iss. 6, 2008-11 ,pp. : 1184-1196

Taylor & Francis Ltd

Access to resources Recommend Favorite

Guest Editorial - Statistical Issues in Adaptive Design Methods in Clinical Trials

By Dragalin Vladimir

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 6, 2007-11 ,pp. : 955-956

Taylor & Francis Ltd

Access to resources Recommend Favorite